Research programme: antifungals - FUJIFILM Toyama Chemical/Arrow Therapeutics
Alternative Names: Antifungals research programme - FUJIFILM Toyama Chemical/Arrow Therapeutics; T-2309Latest Information Update: 29 Oct 2018
At a glance
- Originator Arrow Therapeutics; Toyama Chemical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 26 Apr 2005 Discontinued - Preclinical for Mycoses in Japan (unspecified route)
- 26 Apr 2005 Discontinued - Preclinical for Mycoses in United Kingdom (unspecified route)
- 31 Mar 2004 This programme is still in active development - (BioSquare-2004)